Jupiter Neurosciences (JUNS) Invested Capital (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Invested Capital for 4 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital fell 21.8% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $1.2 million, a 21.8% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 19.73% from the prior year.
• Invested Capital was $1.2 million for Q2 2026 at Jupiter Neurosciences, down from $3.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $4.3 million in Q4 2024 and troughed at -$5.1 million in Q3 2024.
• A 4-year average of $567722.8 and a median of $1.3 million in 2025 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 203.74% in 2024 and decreased 21.8% in 2026, its largest moves.
• Over 4 years, Invested Capital stood at -$4.2 million in 2023, then soared by 203.74% to $4.3 million in 2024, then dropped by 19.73% to $3.5 million in 2025, then plunged by 66.46% to $1.2 million in 2026.
• The last three Invested Capital figures came in at $1.2 million (Q2 2026), $3.5 million (Q4 2025), and $203849.0 (Q3 2025), per Business Quant data.